These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21764212)

  • 1. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
    Steffan JJ; Koul HK
    Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDEF in prostate cancer.
    Sood AK; Kim H; Geradts J
    Prostate; 2012 May; 72(6):592-6. PubMed ID: 21796651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A; Sood AK
    Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
    Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDEF downregulates stathmin expression in prostate cancer.
    Sabherwal Y; Mahajan N; Helseth DL; Gassmann M; Shi H; Zhang M
    Int J Oncol; 2012 Jun; 40(6):1889-99. PubMed ID: 22378487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
    Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
    J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.
    Turner DP; Moussa O; Sauane M; Fisher PB; Watson DK
    Cancer Res; 2007 Feb; 67(4):1618-25. PubMed ID: 17308102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.
    Thelen P; Jarry H; Ringert RH; Wuttke W
    Planta Med; 2004 May; 70(5):397-400. PubMed ID: 15124082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
    Sabherwal Y; Mahajan N; Zhang M
    Oncol Rep; 2013 Oct; 30(4):1985-8. PubMed ID: 23921628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
    Feldman RJ; Sementchenko VI; Gayed M; Fraig MM; Watson DK
    Cancer Res; 2003 Aug; 63(15):4626-31. PubMed ID: 12907642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signatures of prostate-derived Ets factor (PDEF) in cancer.
    Mahajan N
    Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter.
    Chen H; Nandi AK; Li X; Bieberich CJ
    Cancer Res; 2002 Jan; 62(2):338-40. PubMed ID: 11809674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.
    Pal M
    J Cell Physiol; 2019 Nov; 234(11):20266-20274. PubMed ID: 30982973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
    Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
    Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
    Gu X; Zerbini LF; Otu HH; Bhasin M; Yang Q; Joseph MG; Grall F; Onatunde T; Correa RG; Libermann TA
    Cancer Res; 2007 May; 67(9):4219-26. PubMed ID: 17483333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.
    Ghadersohi A; Odunsi K; Lele S; Collins Y; Greco WR; Winston J; Liang P; Sood AK
    Oncol Rep; 2004 Feb; 11(2):453-8. PubMed ID: 14719083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
    Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
    Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
    Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
    Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
    Sood AK; Saxena R; Groth J; Desouki MM; Cheewakriangkrai C; Rodabaugh KJ; Kasyapa CS; Geradts J
    Hum Pathol; 2007 Nov; 38(11):1628-38. PubMed ID: 17521701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
    Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.